Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

Conditions: Relapsed Ovarian Cancer Interventions: Drug: Fluzoparib; Drug: Apatinib Sponsors: Jin Li Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials